No retraction, correction or concern found when last checked on Nov 1, 2026.
Mycothiol biosynthesis is essential for ethionamide susceptibility in Mycobacterium tuberculosis
Catherine Vilchèze, Yossef Av‐Gay, Rodgoun Attarian and 8 more
Molecular Microbiology · 2008
doi:10.1111/j.1365-2958.2008.06365.x
Abstract
Summary Spontaneous mutants of Mycobacterium tuberculosis that were resistant to the anti‐tuberculosis drugs ethionamide and isoniazid were isolated and found to map to mshA , a gene encoding the first enzyme involved in the biosynthesis of mycothiol, a major low‐molecular‐weight thiol in M. tuberculosis . Seven independent missense or frameshift mutations within mshA were identified and characterized. Precise null deletion mutations of the mshA gene were generated by specialized transduction in three different strains of M. tuberculosis . The mshA deletion mutants were defective in mycothiol biosynthesis, were only ethionamide‐resistant and required catalase to grow. Biochemical studies suggested that the mechanism of ethionamide resistance in mshA mutants was likely due to a defect in ethionamide activation. In vivo , a mycothiol‐deficient strain grew normally in immunodeficient mice, but was slightly defective for growth in immunocompetent mice. Mutations in mshA demonstrate the non‐essentiality of mycothiol for growth in vitro and in vivo , and provide a novel mechanism of ethionamide resistance in M. tuberculosis.
Shown for reading. Its publisher allows quoting it, not republishing it.
References 55
- 1.
Banerjee A, Dubnau E, Quemard A, Balasubramanian V, Um KS, Wilson T, et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science. 1994;263:227-230.
Not in our library10.1126/science.8284673
- 2.
Bardarov S, Bardarov S, Pavelka MS, Sambandamurthy V, Larsen M, Tufariello J, et al. Specialized transduction: an efficient method for generating marked and unmarked targeted gene disruptions in Mycobacterium tuberculosis, M. bovis BCG and M. smegmatis. Microbiology. 2002;148:3007-3017.
Not in our library10.1099/00221287-148-10-3007
- 3.
Baulard AR, Betts JC, Engohang-Ndong J, Quan S, McAdam RA, Brennan PJ, et al. Activation of the pro-drug ethionamide is regulated in mycobacteria. J Biol Chem. 2000;275:28326-28331.
Not in our library10.1074/jbc.m003744200
- 4.
Buchmeier N, Fahey RC. The mshA gene encoding the glycosyltransferase of mycothiol biosynthesis is essential in Mycobacterium tuberculosis Erdman. FEMS Microbiol Lett. 2006;264:74-79.
Not in our library10.1111/j.1574-6968.2006.00441.x
- 5.
Buchmeier NA, Newton GL, Koledin T, Fahey RC. Association of mycothiol with protection of Mycobacterium tuberculosis from toxic oxidants and antibiotics. Mol Microbiol. 2003;47:1723-1732.
Not in our library10.1046/j.1365-2958.2003.03416.x
- 6.
Buchmeier NA, Newton GL, Fahey RC. A mycothiol synthase mutant of Mycobacterium tuberculosis has an altered thiol-disulfide content and limited tolerance to stress. J Bacteriol. 2006;188:6245-6252.
Not in our library10.1128/jb.00393-06
- 7.
Cardoso RF, Cooksey RC, Morlock GP, Barco P, Cecon L, Forestiero F, et al. Screening and characterization of mutations in isoniazid-resistant Mycobacterium tuberculosis isolates obtained in Brazil. Antimicrob Agents Chemother. 2004;48:3373-3381.
Not in our library10.1128/aac.48.9.3373-3381.2004
- 8.
- 9.
Dessen A, Quemard A, Blanchard JS, Jacobs WR, Sacchettini JC. Crystal structure and function of the isoniazid target of Mycobacterium tuberculosis. Science. 1995;267:1638-1641.
Not in our library10.1126/science.7886450
- 10.
Dover LG, Alahari A, Gratraud P, Gomes JM, Bhowruth V, Reynolds RC, et al. EthA, a common activator of thiocarbamide-containing drugs acting on different mycobacterial targets. Antimicrob Agents Chemother. 2007;51:1055-1063.
Not in our library10.1128/aac.01063-06
- 11.
Dubos RJ, Middlebrook G. Media for tubercle bacilli. Am Rev Tuberc. 1947;56:334-345.
Not in our library
- 12.
Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006;368:1575-1580.
Not in our library10.1016/s0140-6736(06)69573-1
- 13.
Hazbon MH, Brimacombe M, Bobadilla del Valle M, Cavatore M, Guerrero MI, Varma-Basil M, et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2006;50:2640-2649.
Not in our library10.1128/aac.00112-06
- 14.
Koledin T, Newton GL, Fahey RC. Identification of the mycothiol synthase gene (mshD) encoding the acetyltransferase producing mycothiol in actinomycetes. Arch Microbiol. 2002;178:331-337.
Not in our library10.1007/s00203-002-0462-y
- 15.
Larsen MH, Vilcheze C, Kremer L, Besra GS, Parsons L, Salfinger M, et al. Overexpression of inhA, but not kasA, confers resistance to isoniazid and ethionamide in Mycobacterium smegmatis, M. bovis BCG and M. tuberculosis. Mol Microbiol. 2002;46:453-466.
Not in our library10.1046/j.1365-2958.2002.03162.x
- 16.
Leonardo MR, Dailly Y, Clark DP. Role of NAD in regulating the adhE gene of Escherichia coli. J Bacteriol. 1996;178:6013-6018.
Not in our library10.1128/jb.178.20.6013-6018.1996
- 17.
Lund O, Nielsen M, Lundegaard C, Worning P. CPHmodels 2.0: X3M a Computer Program to Extract 3D Models. 2002.
Not in our library
- 18.
Marrakchi H, Laneelle G, Quemard A. InhA, a target of the antituberculous drug isoniazid, is involved in a mycobacterial fatty acid elongation system, FAS-II. Microbiology. 2000;146(Part 2):289-296.
Not in our library10.1099/00221287-146-2-289
- 19.
Martin A, Morcillo N, Lemus D, Montoro E, Telles MA, Simboli N, et al. Multicenter study of MTT and resazurin assays for testing susceptibility to first-line anti-tuberculosis drugs. Int J Tuberc Lung Dis. 2005;9:901-906.
Not in our library
- 20.
Middlebrook G. Isoniazid resistance and catalase activity of tubercle bacilli. Am Rev Tuberc. 1954;69:471-472.
Not in our library10.1164/art.1954.69.3.471
- 21.
Middlebrook G, Cohn ML, Schaefer WB. Studies on isoniazid and tubercle bacilli. III. The isolation, drug-susceptibility, and catalase-testing of tubercle bacilli from isoniazid-treated patients. Am Rev Tuberc. 1954;70:852-872.
Not in our library10.1164/art.1954.70.5.852
- 22.
Miesel L, Weisbrod TR, Marcinkeviciene JA, Bittman R, Jacobs WR. NADH dehydrogenase defects confer isoniazid resistance and conditional lethality in Mycobacterium smegmatis. J Bacteriol. 1998;180:2459-2467.
Not in our library10.1128/jb.180.9.2459-2467.1998
- 23.
Morlock GP, Metchock B, Sikes D, Crawford JT, Cooksey RC. ethA, inhA, and katG loci of ethionamide-resistant clinical Mycobacterium tuberculosis isolates. Antimicrob Agents Chemother. 2003;47:3799-3805.
Not in our library10.1128/aac.47.12.3799-3805.2003
- 24.
Newton GL, Fahey RC. Mycothiol biochemistry. Arch Microbiol. 2002;178:388-394.
Not in our library10.1007/s00203-002-0469-4
- 25.
Newton GL, Arnold K, Price MS, Sherrill C, Delcardayre SB, Aharonowitz Y, et al. Distribution of thiols in microorganisms: mycothiol is a major thiol in most actinomycetes. J Bacteriol. 1996;178:1990-1995.
Not in our library10.1128/jb.178.7.1990-1995.1996
- 26.
Newton GL, Unson MD, Anderberg SJ, Aguilera JA, de Oh NNI, Cardayre SB, et al. Characterization of Mycobacterium smegmatis mutants defective in 1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside and mycothiol biosynthesis. Biochem Biophys Res Commun. 1999;255:239-244.
Not in our library10.1006/bbrc.1999.0156
- 27.
Newton GL, Av-Gay Y, Fahey RC. A novel mycothiol-dependent detoxification pathway in mycobacteria involving mycothiol S-conjugate amidase. Biochemistry. 2000a;39:10739-10746.
Not in our library10.1021/bi000356n
- 28.
Newton GL, Av-Gay Y, Fahey RC. N-acetyl-1-D-myo-inosityl-2-amino-2-deoxy-alpha-D-glucopyranoside deacetylase (MshB) is a key enzyme in mycothiol biosynthesis. J Bacteriol. 2000b;182:6958-6963.
Not in our library10.1128/jb.182.24.6958-6963.2000
- 29.
Newton GL, Koledin T, Gorovitz B, Rawat M, Fahey RC, Av-Gay Y. The glycosyltransferase gene encoding the enzyme catalyzing the first step of mycothiol biosynthesis (mshA). J Bacteriol. 2003;185:3476-3479.
Not in our library10.1128/jb.185.11.3476-3479.2003
- 30.
Newton GL, Ta P, Bzymek KP, Fahey RC. Biochemistry of the initial steps of mycothiol biosynthesis. J Biol Chem. 2006;281:33910-33920.
Not in our library10.1074/jbc.m604724200
- 31.
Piatek AS, Telenti A, Murray MR, El-Hajj H, Jacobs WR, Kramer FR, Alland D. Genotypic analysis of Mycobacterium tuberculosis in two distinct populations using molecular beacons: implications for rapid susceptibility testing. Antimicrob Agents Chemother. 2000;44:103-110.
Not in our library10.1128/aac.44.1.103-110.2000
- 32.
Quemard A, Laneelle G, Lacave C. Mycolic acid synthesis: a target for ethionamide in mycobacteria? Antimicrob Agents Chemother. 1992;36:1316-1321.
Not in our library10.1128/aac.36.6.1316
- 33.
Quemard A, Sacchettini JC, Dessen A, Vilcheze C, Bittman R, Jacobs WR, Blanchard JS. Enzymatic characterization of the target for isoniazid in Mycobacterium tuberculosis. Biochemistry. 1995;34:8235-8241.
Not in our library10.1021/bi00026a004
- 34.
Ramaswamy SV, Reich R, Dou SJ, Jasperse L, Pan X, Wanger A, et al. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2003;47:1241-1250.
Not in our library10.1128/aac.47.4.1241-1250.2003
- 35.
Rawat M, Kovacevic S, Billman-Jacobe H, Av-Gay Y. Inactivation of mshB, a key gene in the mycothiol biosynthesis pathway in Mycobacterium smegmatis. Microbiology. 2003;149:1341-1349.
Not in our library10.1099/mic.0.26084-0
- 36.
Rawat M, Johnson C, Cadiz V, Av-Gay Y. Comparative analysis of mutants in the mycothiol biosynthesis pathway in Mycobacterium smegmatis. Biochem Biophys Res Commun. 2007;363:71-76.
Not in our library10.1016/j.bbrc.2007.08.142
- 37.
Rozwarski DA, Grant GA, Barton DH, Jacobs WR, Sacchettini JC. Modification of the NADH of the isoniazid target (InhA) from Mycobacterium tuberculosis. Science. 1998;279:98-102.
Not in our library10.1126/science.279.5347.98
- 38.
San KY, Bennett GN, Berrios-Rivera SJ, Vadali RV, Yang YT, Horton E, et al. Metabolic engineering through cofactor manipulation and its effects on metabolic flux redistribution in Escherichia coli. Metab Eng. 2002;4:182-192.
Not in our library10.1006/mben.2001.0220
- 39.
Sareen D, Newton GL, Fahey RC, Buchmeier NA. Mycothiol is essential for growth of Mycobacterium tuberculosis Erdman. J Bacteriol. 2003;185:6736-6740.
Not in our library10.1128/jb.185.22.6736-6740.2003
- 40.
Cited by papers we hold 7
- Genome-Scale Metabolic Modeling for Unraveling Molecular Mechanisms of High Threat Pathogens · 2020Not checked
- Machine learning and structural analysis of Mycobacterium tuberculosis pan-genome identifies genetic signatures of antibiotic resistance · 2018No notice
- Molecular Targets Related Drug Resistance Mechanisms in MDR-, XDR-, and TDR-Mycobacterium tuberculosis Strains · 2018No notice
- Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain · 2015No notice
- Reengineering Redox Sensitive GFP to Measure Mycothiol Redox Potential of Mycobacterium tuberculosis during Infection · 2014No notice
- Drug Resistance Mechanisms in Mycobacterium tuberculosis · 2014No notice
- Evolution of extensively drug-resistant Mycobacterium tuberculosisfrom a susceptible ancestor in a single patient · 2014No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.